thiophenes has been researched along with Dyskinesia, Drug-Induced in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boroojerdi, B; Giladi, N; Surmann, E | 1 |
| Jenner, P | 1 |
| Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S | 1 |
| Gerlach, M; Gruenblatt, E; Heindl, M; Lebsanft, H; Mayerhofer, A; Riederer, P; Scheller, DK; Schmidt, WJ | 1 |
| Iravani, MM; Jackson, MJ; Jenner, P; Olanow, CW; Rose, S; Scheller, D; Smith, LA; Stockwell, KA; Tayarani-Binazir, K | 1 |
| Iravani, MM; Jackson, MJ; Jenner, P; Rose, S; Scheller, DK; Smith, LA; Stockwell, KA | 1 |
| Albayrak, Y; Ekinci, O | 1 |
| Deuschle, M; Mase, E; Zink, M | 1 |
| LeWitt, PA; Lyons, KE; Pahwa, R | 1 |
| Bédard, PJ; Britton, DR; Grondin, R; Shiosaki, K | 1 |
| Britton, DR; Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Shiosaki, K | 1 |
1 review(s) available for thiophenes and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Wearing off, dyskinesia, and the use of continuous drug delivery in Parkinson's disease.
Topics: Animals; Clinical Trials as Topic; Dopamine Agonists; Drug Delivery Systems; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2013 |
2 trial(s) available for thiophenes and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.
Topics: Adolescent; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Survival Analysis; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2013 |
Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.
Topics: Administration, Cutaneous; Aged; Dopamine Agonists; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Dyskinesia, Drug-Induced; Erythema; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pruritus; Tetrahydronaphthalenes; Thiophenes; Time Factors; Treatment Outcome | 2007 |
8 other study(ies) available for thiophenes and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases | 2016 |
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.
Topics: Adrenergic Agents; Animals; Dopamine Agonists; Dyskinesia, Drug-Induced; Dyskinesias; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Tetrahydronaphthalenes; Thiophenes | 2008 |
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; Motor Skills; MPTP Poisoning; Tetrahydronaphthalenes; Thiophenes | 2009 |
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets.
Topics: Animals; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Statistics, Nonparametric; Tetrahydronaphthalenes; Thiophenes; Time Factors | 2010 |
Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.
Topics: Depressive Disorder; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Female; Fluvoxamine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2012 |
Dyskinesia during treatment with duloxetine.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Female; Humans; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Thiophenes | 2006 |
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinolones; Quinpirole; Receptors, Dopamine D1; Thiophenes | 1997 |
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzopyrans; Callithrix; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Quinolones; Receptors, Dopamine D1; Thiophenes | 1999 |